Ash A Alizadeh Selected Research

Ash A Alizadeh Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 04/2005
15	Lymphoma (Lymphomas) 03/2022 - 10/2009
10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 04/2003
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 04/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 10/2015
6	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022 - 02/2011
6	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
6	Residual Neoplasm 01/2022 - 10/2015
4	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2012
3	Disease Progression 10/2020 - 09/2004
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 07/2012
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 09/2004
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017 - 09/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2010 - 05/2010
2	Infections 01/2022 - 03/2012
2	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 12/2020
2	Adenocarcinoma 01/2020 - 01/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 12/2010
2	Melanoma (Melanoma, Malignant) 01/2019 - 07/2012
2	T-Cell Lymphoma (Lymphoma, T Cell) 09/2012 - 03/2012
1	COVID-19 03/2022
1	Frailty 01/2022
1	Glioma (Gliomas) 12/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Pain (Aches) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 11/2019
1	Leiomyosarcoma 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 11/2017
1	Extranodal Extension 01/2017
1	B-Cell Leukemia (Leukemia, B Cell) 03/2015
1	Genetic Translocation (Chromosomal Translocation) 12/2014
1	Multiple Myeloma 07/2014
1	Inflammation (Inflammations) 07/2013

Drug/Important Bio-Agent (IBA)

20	Circulating Tumor DNAIBA 05/2022 - 05/2014
15	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2003
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
8	Proteins (Proteins, Gene)FDA Link 11/2017 - 01/2004
7	Monoclonal AntibodiesIBA 01/2022 - 10/2009
7	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 02/2013
6	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2016
6	AntigensIBA 01/2020 - 01/2002
4	RNA (Ribonucleic Acid)IBA 12/2020 - 05/2015
3	Biological ProductsIBA 01/2022 - 11/2016
3	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2017 - 07/2010
3	Phosphotransferases (Kinase)IBA 01/2017 - 01/2013
3	Rituximab (Mabthera)FDA Link 04/2013 - 09/2010
3	Messenger RNA (mRNA)IBA 07/2012 - 07/2010
2	ChromatinIBA 01/2022 - 03/2015
2	Immune Checkpoint InhibitorsIBA 10/2020 - 01/2019
2	VaccinesIBA 01/2020 - 11/2019
2	Peptides (Polypeptides)IBA 11/2019 - 01/2017
2	Immunoglobulin Variable RegionIBA 01/2017 - 11/2012
2	Interleukin-6 (Interleukin 6)IBA 07/2013 - 01/2004
2	Interleukin-4 (Interleukin 4)IBA 07/2013 - 04/2005
2	AntibodiesIBA 04/2012 - 09/2010
2	Complementary DNA (cDNA)IBA 08/2003 - 04/2002
1	Immunoglobulin G (IgG)IBA 03/2022
1	Neutralizing AntibodiesIBA 03/2022
1	Blocking AntibodiesIBA 03/2022
1	Ad26COVS1IBA 01/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	SphingosineIBA 01/2022
1	AnthracyclinesIBA 01/2022
1	Flucytosine (Ancobon)FDA Link 12/2020
1	GlutaminaseIBA 12/2020
1	vocimagene amiretrorepvecIBA 12/2020
1	Hormones (Hormone)IBA 01/2020
1	AndrogensIBA 01/2020
1	NucleotidesIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2019
1	EpitopesIBA 11/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Phospholipases (Phospholipase)IBA 01/2017
1	Syk KinaseIBA 01/2017
1	src-Family KinasesIBA 01/2017
1	Biological FactorsIBA 11/2016
1	ErbB Receptors (EGF Receptor)IBA 10/2016
1	rociletinibIBA 10/2016
1	MHC class II transactivator proteinIBA 03/2015
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 07/2014
1	Vincristine (Oncovin)FDA LinkGeneric 06/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014
1	Prednisone (Sone)FDA LinkGeneric 06/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2014

Therapy/Procedure

31	Therapeutics 01/2022 - 10/2009
9	Immunotherapy 12/2020 - 09/2012
5	Drug Therapy (Chemotherapy) 05/2022 - 07/2010
4	Radiotherapy 12/2020 - 10/2015
3	Aftercare (After-Treatment) 01/2020 - 10/2015
1	Stem Cell Transplantation 01/2020
1	Chemoradiotherapy 01/2020
1	Salvage Therapy 01/2020
1	Surgical Instruments (Clip) 01/2020
1	Precision Medicine 07/2014